MP-0423

N/A

Report date: 2024/12/02 11:49:12

Base Information

Drug NameMP-0423
Drug Alias NameMP-0423
ClassificationBiologics > Protein drugs
Mechanisms of ActionVirus internalization inhibitors
TargetsUpdating
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMolecular Partners Ag
China Registration ClassN/A

Develop Information

Active CompaniesNovartis Pharma AgMolecular Partners Ag
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A